Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Stereotactic radiation therapy for oligometastatic esophagogastric adenocarcinoma: outcome and prognostic factors.
Franceschini D, Teriaca MA, Di Cristina L, Vernier V, Lo Faro L, Franzese C, Comito T, Clerici E, Bellu L, Dominici L, Spoto R, Massaro M, Navarria P, Scorsetti M. Franceschini D, et al. Among authors: spoto r. Br J Radiol. 2023 Mar 1;96(1144):20220771. doi: 10.1259/bjr.20220771. Epub 2023 Mar 3. Br J Radiol. 2023. PMID: 36809197 Free PMC article.
HALFMOON TomoTherapy (Helical ALtered Fractionation for iMplant partial OmissiON): implant-sparing post-mastectomy radiotherapy reshaping the clinical target volume in the reconstructed breast.
Leonardi MC, Spoto R, Miglietta E, Trivellato S, La Rocca E, Luraschi R, Grosso P, De Lorenzi F, Fodor C, Dicuonzo S, Dell'Acqua V, Gerardi MA, Morra A, Francia CM, Rietjens M, Galimberti VE, Veronesi P, Orecchia R, Cattani F, Jereczek-Fossa BA. Leonardi MC, et al. Among authors: spoto r. J Cancer Res Clin Oncol. 2019 Jul;145(7):1887-1896. doi: 10.1007/s00432-019-02938-8. Epub 2019 May 29. J Cancer Res Clin Oncol. 2019. PMID: 31144158
Long term results of a phase II trial of hypofractionated adjuvant radiotherapy for early-stage breast cancer with volumetric modulated arc therapy and simultaneous integrated boost.
Franceschini D, Fogliata A, Spoto R, Dominici L, Lo Faro L, Franzese C, Comito T, Lobefalo F, Reggiori G, Cozzi L, Sagona A, Gentile D, Scorsetti M. Franceschini D, et al. Among authors: spoto r. Radiother Oncol. 2021 Nov;164:50-56. doi: 10.1016/j.radonc.2021.09.006. Epub 2021 Sep 17. Radiother Oncol. 2021. PMID: 34537289 Clinical Trial.
Preservation of Axillary Lymph Nodes Compared with Complete Dissection in T1-2 Breast Cancer Patients Presenting One or Two Metastatic Sentinel Lymph Nodes: The SINODAR-ONE Multicenter Randomized Clinical Trial.
Tinterri C, Gentile D, Gatzemeier W, Sagona A, Barbieri E, Testori A, Errico V, Bottini A, Marrazzo E, Dani C, Dozin B, Boni L, Bruzzi P, Fernandes B, Franceschini D, Spoto R, Torrisi R, Scorsetti M, Santoro A, Canavese G; SINODAR-ONE Collaborative Group. Tinterri C, et al. Among authors: spoto r. Ann Surg Oncol. 2022 Sep;29(9):5732-5744. doi: 10.1245/s10434-022-11866-w. Epub 2022 May 12. Ann Surg Oncol. 2022. PMID: 35552930 Clinical Trial.
Locally Advanced Non-Small Cell Lung Cancer: Clinical Outcome, Toxicity and Predictive Factors in Patients Treated with Hypofractionated Sequential or Exclusive Radiotherapy.
Massaro M, Franceschini D, Spoto R, Dominici L, Franzese C, Baldaccini D, Marini B, di Cristina L, Marzo MA, Lo Faro L, Paganini L, Reggiori G, Galdieri C, Testori A, Scorsetti M. Massaro M, et al. Among authors: spoto r. Curr Oncol. 2022 Jul 12;29(7):4893-4901. doi: 10.3390/curroncol29070388. Curr Oncol. 2022. PMID: 35877248 Free PMC article.
Training and validation of a knowledge-based dose-volume histogram predictive model in the optimisation of intensity-modulated proton and volumetric modulated arc photon plans for pleural mesothelioma patients.
Franceschini D, Cozzi L, Fogliata A, Marini B, Di Cristina L, Dominici L, Spoto R, Franzese C, Navarria P, Comito T, Reggiori G, Tomatis S, Scorsetti M. Franceschini D, et al. Among authors: spoto r. Radiat Oncol. 2022 Aug 26;17(1):150. doi: 10.1186/s13014-022-02119-x. Radiat Oncol. 2022. PMID: 36028862 Free PMC article.
Salvage Mastectomy Is not the Treatment of Choice for Aggressive Subtypes of Ipsilateral Breast Cancer Recurrence: A Single-Institution Retrospective Study.
Gentile D, Sagona A, Spoto R, Franceschini D, Vaccari S, Vinci V, Biondi E, Scardina L, Tinterri C. Gentile D, et al. Among authors: spoto r. Eur J Breast Health. 2022 Oct 1;18(4):315-322. doi: 10.4274/ejbh.galenos.2022.2022-5-3. eCollection 2022 Oct. Eur J Breast Health. 2022. PMID: 36248756 Free PMC article.
Stereotactic Body Radiation Therapy for Lung and Liver Oligometastases from Breast Cancer: Toxicity Data of a Prospective Non-Randomized Phase II Trial.
Franceschini D, Comito T, Di Gallo A, Vernier V, Marzo MA, Di Cristina L, Marini B, Lo Faro L, Stefanini S, Spoto R, Dominici L, Franzese C, Scorsetti M. Franceschini D, et al. Among authors: spoto r. Curr Oncol. 2022 Oct 17;29(10):7858-7867. doi: 10.3390/curroncol29100621. Curr Oncol. 2022. PMID: 36290898 Free PMC article. Clinical Trial.
26 results